Search
for
Sort by
Research 601–630 of 759
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- Men’s baldness stigma: A mixed methods international survey
- Common contact allergens implicated in frontal fibrosing alopecia found in over-the-counter hair growth serums and solutions
- A Global Survey of Ethnic Indian Women Living with Polycystic Ovary Syndrome: Co-Morbidities, Concerns, Diagnosis Experiences, Quality of Life, and Use of Treatment Methods
- Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series
- Safety and efficacy of ALRV5XR in men with androgenetic alopecia: A randomised, double-blinded, placebo-controlled clinical trial
- Neurosarcoidosis Occurring 6 Years after Onset of Vogt-Koyanagi-Harada Disease
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Cell-Free Fat Extract (Ceffe) Combined with GelMA Hydrogel to Improve the Survival Rate of Random Skin Flaps in Mice
- Perceived Stigma Among Adults With Alopecia Areata in the United States
- Health-related quality of life and mental state in women with polycystic ovary syndrome and migration or minority background – A cross-sectional study
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Feasibility and acceptability of an online multicomponent very low-carbohydrate intervention in young adult women with obesity: a pilot study
- Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia
- Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data
- The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- A Case Series and Literature Review of Telogen Effluvium and Alopecia Universalis after the Administration of a Heterologous COVID-19 Vaccine Scheme
- Oral Low-Dose Naltrexone in the Treatment of Frontal Fibrosing Alopecia and Lichen Planopilaris: An Uncontrolled Open-Label Prospective Study
- Polycystic ovary syndrome and iron overload: biochemical link and underlying mechanisms with potential novel therapeutic avenues
- COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy
- The current state of lesbian, gay, bisexual, and transgender cultural competency among U.S. dermatology residents
- Comparison of a Novel Silicone Gel Wound Dressing vs Bacitracin After Follicular Unit Extraction Hair Transplantation
- Familial Frontal Fibrosing Alopecia
- Characterization of pubertal development of girls in rural Bangladesh
- A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation: A Report of Five Cases
- The impact of obesity on the folliculosebaceous unit
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury
- Real-world safety of Tepotinib: Insights from the Food and Drug Administration Adverse Event Reporting System